South Korean Delegation Visits Teva

Teva hosted a delegation of business executives from South Korea last month, headed by Young Jin Kim, Chairman and CEO of Handok - Teva's business partner in South Korea. During their visit, guests learned about Teva’s position in both the Israeli and global pharmaceutical industry, and were treated to a tour of Teva’s tablet manufacturing plant in Kfar Saba, Israel.
South Korean Delegation Visits Teva
From right to left: Tomer Amitai, Young Jin Kim and Barak Hamdani

Step towards strengthening the collaboration between Teva and Handok

On June 29th, Teva's site in Kfar Saba was visited by a delegation of business executives from South Korea. The delegation, headed by Young Jin Kim, Chairman and CEO of Handok - Teva's business partner in South Korea - included senior representatives from pharmaceutical and other companies.

"Teva believes it is extremely important to strengthen the relationship with the business community in South Korea, as well as expanding the collaboration with Handok and other pharmaceutical companies in the country", says Tomer Amitai, VP, Corporate Coordination & Support, Office of the President and CEO at Teva, who coordinated the visit along with Barak Hamdani, Head of the Kfar Saba Campus, in association with Corporate Communications and the headquarters of Teva Japan-South Korea.


During their visit, the guests attended a lecture about Teva and its position in the Israeli and global industry, and took a tour of the tablet factory in Kfar Saba.

The Teva-Handok business venture was launched in February 2013. Teva contributes its global resources, with responsibilities for manufacturing and supplying a wide range of affordable and innovative medicines. Handok’s primary responsibility are in sales and marketing, distribution, and regulatory affairs. Teva has a controlling stake in the business venture, with a profit split of 51% for Teva and 49% for Handok.

For more details on Teva’s South Korea venture >>

For the press release on the South Korea venture >>